Scrip Asks…What Does 2024 Hold for Biopharma?

Jan 2024

James West, Managing Director in Lincoln’s Healthcare Group, recently discussed his expectations for the biopharma market in 2024 as part of Scrip’s series.

Summary

Contributor

Meet Professionals with Complementary Expertise in Mergers & Acquisitions

Related Perspectives in Mergers & Acquisitions

The Fitness Investment Landscape

State of the Fitness Market: presented by L.E.K. Consulting Fitness Market Stabilization and Return to Growth Few industries were as negatively impacted by COVID-19 as the in-person fitness industry. Deemed… Read More

Lincoln International adds Jonathan Kaufman as Managing Director

Lincoln International, a global investment banking advisory firm, is pleased to announce that Jonathan Kaufman has joined as a Managing Director in the firm’s Technology, Media & Telecom (TMT) Group… Read More

Echoes of Innovation in Audio Electronics

Lincoln International recently advised Transom Capital Group on its sale of Mackie to RØDE Microphones. Mackie is a leading audio products company that designs and markets solutions for creators, whether… Read More

Lincoln International adds Carlos Candil as Managing Director

Lincoln International, a global investment banking advisory firm, is pleased to announce that Carlos Candil has joined the London office as a Managing Director in the firm’s Energy, Power &… Read More